CLS Brevius Stem with Kinectiv Technology
by Zimmer GmbH
510(k) K110836
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK110836 | Date7 Oct 2011 | StatusActive |
Official records
- FDA 510(k) database K110836
Recalls
-
- Terminated Z-0319-2020
Non-highly polished implants may adhere to the LDPE bag (previous packaging configuration).
Timeline
- Cleared FDA 510(k) K110836
- Recall initiated FDA recalls Z-0319-2020
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- KWA
- Device class
- Class III
- Regulation
- 21 CFR Part 888.3330
- Advisory committee
- Orthopedic
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The CLS Brevius Stem with Kinectiv Technology is a Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component) designed for primary total hip arthroplasty. This modular femoral stem features Kinectiv Technology, integrating with Zimmer’s modular neck system to enhance anatomical fit and stability in hip replacement procedures.
Intended for uncemented use, the device is supplied as a reusable surgical implant and is regulated under FDA 510(k) clearance (K110836). It is classified as a Class III medical device under the FDA’s regulatory framework, with multiple FEI numbers (e.g., 3020282716) and registration numbers (e.g., 8043792) associated with its variants. Storage and handling follow standard orthopedic implant protocols, adhering to manufacturer guidelines for sterility and surgical preparation.